Correlation Between Werewolf Therapeutics and Acrivon Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Werewolf Therapeutics and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Werewolf Therapeutics and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Acrivon Therapeutics,.

Diversification Opportunities for Werewolf Therapeutics and Acrivon Therapeutics,

0.1

Correlation Coefficient

Werewolf Therapeutics  Acrivon Therapeutics,

Average diversification

The 3 months correlation between Werewolf and Acrivon is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Acrivon Therapeutics, go up and down completely randomly.

Pair Corralation between Werewolf Therapeutics and Acrivon Therapeutics,

Given the investment horizon of 90 days Werewolf Therapeutics is expected to generate 12.21 times less return on investment than Acrivon Therapeutics,. In addition to that, Werewolf Therapeutics is 1.26 times more volatile than Acrivon Therapeutics, Common. It trades about 0.01 of its total potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.09 per unit of volatility. If you would invest  586.00  in Acrivon Therapeutics, Common on June 30, 2024 and sell it today you would earn a total of  130.00  from holding Acrivon Therapeutics, Common or generate 22.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Werewolf Therapeutics  vs.  Acrivon Therapeutics, Common

Werewolf Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Werewolf Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Werewolf Therapeutics is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Acrivon Therapeutics,

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Acrivon Therapeutics, Common are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Acrivon Therapeutics, showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Werewolf Therapeutics and Acrivon Therapeutics,

The main advantage of trading using opposite Werewolf Therapeutics and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.

The idea behind Werewolf Therapeutics and Acrivon Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.